Saturday, Oct. 31, 2020
8:00 a.m.-1:35 p.m. MST
Organizers:
Emmanuel Katsanis, MD – University of Arizona
Ali McBride, PharmD, MS, BCPS, BCOP, FAzPA – University of Arizona Cancer Center
Rachna Shroff, MD, MS – University of Arizona Cancer Center
ACI Tucson Program Registration
Registration for the live virtual Tucson program is NOW OPEN. Registration will close at 8:00 a.m. MST on October 31. 2020. You must be registered to attend the program.
Program Agenda
7:45–8:00 a.m.
|
Welcome, Introduction, SITC Resources
|
Session I: Introduction to Cancer Immunotherapy
|
8:00–8:30 a.m.
|
Basic Principles of Cancer Immunotherapy Richard J. Simpson, PhD, FACSM – University of Arizona
|
Session II: Immunotherapy in Practice
|
8:30–9:00 a.m.
|
Immunotherapy for the Treatment of Skin Cancers Montaser Shaheen, MD – University of Arizona
|
9:00–9:30 a.m.
|
Immunotherapy for the Treatment of Lung Cancer Ricklie A. Julian, MD – University of Arizona Cancer Center
|
9:30–10:00 a.m.
|
Immunotherapy for the Treatment of Head and Neck Cancers Julie Bauman, MD, MPH – University of Arizona Cancer Center
|
10:00–10:15 a.m.
|
Break
|
10:15–10:45 a.m.
|
Immunotherapy for the Treatment of Genitourinary Malignancies Edward P. Gelmann, MD – University of Arizona
|
10:45–11:15 a.m.
|
Immunotherapy for the Treatment of Hematologic Malignancies Muhammad Husnain, MD – University of Arizona
|
11:15–11:45 a.m.
|
Immunotherapy for the Treatment of Additional Solid Tumors: MSI-high Cancer and Hepatocellular Carcinoma Aaron J. Scott, MD – University of Arizona Cancer Center
|
11:45 a.m.–12:00 p.m.
|
Break
|
Session III: Immunotherapy Challenges and Beyond
|
12:00–12:30 p.m.
|
Toxicity Management Alejandro Recio-Boiles, MD, FACP – University of Arizona Cancer Center
|
12:30–1:00 p.m.
|
Practical Barriers in Cancer Immunotherapy Ali McBride, PharmD, MS, BCPS, BCOP, FAzPA – University of Arizona Cancer Center
|
1:00–1:30 p.m.
|
What's Next for Cancer Immunotherapy? Marina Baretti, MD – The Sidney Kimmel Comprehensive Cancer Center
|
1:30–1:35 p.m.
|
Closing Remarks
|